@article{8120e39dec3c401490651787976ecd78,
title = "Efficacy of booster doses in augmenting waning immune responses to COVID-19 vaccine in patients with cancer",
author = "Shapiro, \{Lauren C.\} and Astha Thakkar and Campbell, \{Sean T.\} and Forest, \{Stefanie K.\} and Kith Pradhan and Gonzalez-Lugo, \{Jesus D.\} and Ryann Quinn and Bhagat, \{Tushar D.\} and Choudhary, \{Gaurav S.\} and Margaret McCort and Sica, \{R. Alejandro\} and Mendel Goldfinger and Swati Goel and Anampa, \{Jesus D.\} and David Levitz and Ariel Fromowitz and Shah, \{Akash Pradip\} and Charlotte Sklow and Gregory Alfieri and Andrew Racine and Lucia Wolgast and Lee Greenberger and Amit Verma and Balazs Halmos",
note = "Funding Information: The authors would like to acknowledge the help of Tanya Riedl and the Montefiore Vaccine Center. The authors acknowledge LLS Award IRV-BC0004-22 , Cancer Center grant P30 CA013330 , and NCORP grant 2UG1CA189859-06 in providing funding for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding Information: The authors would like to acknowledge the help of Tanya Riedl and the Montefiore Vaccine Center. The authors acknowledge LLS Award IRV-BC0004-22, Cancer Center grant P30 CA013330, and NCORP grant 2UG1CA189859-06 in providing funding for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. L.C.S. A.T. A.V. and B.H. conceived and managed the study; J.D.G.-L. R.Q. M.M. R.A.S. M.G. S.G. J.D.A.M. D.L. A.F. A.P.S. C.S. G.A. and L.G. participated in patient recruitment; L.C.S. A.T. J.D.G.-L. R.Q. C.S. and G.A participated in data curation; T.D.B. and G.S.C. participated in laboratory investigations; K.P. oversaw data analyses; A.R. contributed to project administration; S.C. S.F. and L.W. oversaw investigations. All authors contributed to writing the manuscript. R.A.S. serves as a consultant with Morphosys and Miragen and is on the faculty at Physicians? Education Research. A.V. has received research funding from GlaxoSmithKline, BMS, Janssen, Incyte, MedPacto, Celgene, Novartis, Curis, Prelude, and Eli Lilly and Company; has received compensation as a scientific advisor to Novartis, Stelexis Therapeutics, Acceleron Pharma, and Celgene; and has equity ownership in Stelexis Therapeutics. All other authors declare no competing interests.",
year = "2022",
month = jan,
day = "10",
doi = "10.1016/j.ccell.2021.11.006",
language = "English (US)",
volume = "40",
pages = "3--5",
journal = "Cancer Cell",
issn = "1535-6108",
publisher = "Cell Press",
number = "1",
}
